What do Bradesco's latest published quarterly results show? Using Banco Bradesco S.A.'s (BBDC4) third-quarter 2026 press release and Economic and Financial Analysis Report, furnished on Form 6-K and filed with the SEC on October 23, 2026, explain in plain language what the report says, what drove recurring net income, how credit quality and provisions moved, what the capital increase changes, what the risks are and what to watch next. Use the company's own figures and describe rather than recommend.

Claude Haiku 4.5

Banco Bradesco S.A. reported recurring net income of R$7.1 billion for the third quarter of 2026 in its 3Q26 press release and Economic and Financial Analysis Report, filed on Form 6-K on October 23, 2026 (https://www.sec.gov/Archives/edgar/data/1160330/000129281426004994/bbdpr3q26_6k.htm). That was up 0.8% q/q and 14.6% from 3Q25. Nine-month recurring net income reached R$20.97 billion, up 15.6%. Reported net income rose 6.2% to R$19.19 billion over nine months, after R$1.78 billion of non-recurring charges tied to PTI adherence and tax provisions. Total revenue was R$38.0 billion, up 1.1% q/q and 8.4% y/y.

Net interest income rose 2.4% q/q to R$21.4 billion. Client NII was R$20.5 billion, up 1.5%, which the document attributes to a larger loan book and a positive calendar (number of days) effect. Those factors offset the products/segment mix, which reflects a more moderate appetite for credit origination; the gross client margin averaged 8.9%, down 0.2 points q/q. Market NII reached R$875 million, up 30% from R$673 million. By my computation, market NII was about 4% of total NII but supplied about R$202 million, or roughly 40%, of the R$500 million quarterly NII rise; client NII added R$298 million. The document names market NII and fee income as the two positive standouts. Fee income rose 4.2% to R$10.9 billion, led by a record R$4.8 billion of card income. Insurance income fell 8.6% q/q to R$5.6 billion, although the insurance group still earned R$2.9 billion at a 22.0% ROAE. Operating expenses fell 0.7% to R$16.3 billion, and the efficiency ratio improved to 45.4%, down 1.1 points q/q and 4.7 points y/y.

Credit costs were the main offset. Expanded loan loss provisions reached R$10.6 billion, up 6.6% q/q and 24.3% y/y, and client NII net of provisions fell 3.5% q/q to R$9.9 billion. Cost of risk was 3.7%, a slight increase. Over-90-day delinquency rose to 4.6% of loans, up 0.3 points q/q and 0.5 points y/y. MSME working-capital lines backed by federal guarantees account for almost half of the increase, management says. Coverage of Stage 3 movements (loan loss provision expense divided by Stage 3 movements before write-offs) was 83% in the quarter and 94% for nine months; excluding government emergency programs, the document says coverage would exceed 100%. In my view, the highlights' "slightly below 100%" fits 83% less well than the nine-month 94%; check the note. The expanded loan portfolio totaled R$1.15 trillion, up 11.1% y/y, with secured loans at 61.2%.

The company completed the R$10 billion capital increase, which has Central Bank approval, and allocated R$4.1 billion of interest on capital. The Basel total ratio rose to 16.0% and common equity to 12.1%, from 15.5% and 11.3% in June. The document shows consolidated ROAE of 16.1%, which it flags as excluding the capital increase. The increase enlarges the equity base, and the insurance group's ROAE was 22.0%.

Management describes a deteriorating macro backdrop of high rates, a slowing economy, high household debt service and tight financial conditions. It expects slower credit revenues. It names card fees, asset management, consortia and capital markets as the fee lines that accelerated, and says its stance is a cautious credit mix and expanding non-credit revenue streams. The economic table projects a 13.25% year-end 2026 Selic and 1.7% GDP growth.

Readers may want to watch whether delinquency and cost of risk stabilize as guaranteed MSME lines and rural installments mature, whether Stage 3 coverage returns to or above 100%, and whether client NII net of provisions recovers. Against annual guidance, my own computation puts nine-month NII net of provisions of R$32.0 billion at 67% to 76% of the R$42 to R$48 billion range. Nine-month fee growth of 3.6% sits within the 3% to 5% guidance, while nine-month insurance income growth of 8.6% is above the 6% to 8% range.

Claude Opus 5

The primary is accurate and well proportioned. It correctly identifies credit costs as the main offset to a strong revenue quarter. It also separates recurring from book net income, and its own computation that market NII (about 4% of NII) supplied about R$202 million of the R$500 million quarterly NII rise is a useful warning, since market NII was only R$99 million in 3Q25.

Three judgment calls still need work. First, the ROAE paragraph quotes 16.1% "excluding the capital increase" but never gives the unadjusted figure. It then sets it beside the insurance group's 22.0%, which compares a bank-wide number with one segment and could leave readers thinking the bank's return was higher than reported. Second, the guidance check is selective. It covers NII net of provisions, fees and insurance but leaves out two lines that fall outside their ranges: the expanded loan portfolio grew 11.1% y/y against 8.5% to 10.5% guidance, and nine-month operating expenses rose 3.2% against 6% to 8%. Calling insurance "above" its range on nine-month growth of 8.6% also skips the trend, since 3Q insurance income fell 8.6% q/q and 2.0% y/y. Third, "Operating expenses fell 0.7%" depends mostly on the "other" line. Personnel plus administrative expenses rose 0.2% q/q, and civil, labor and tax contingencies rose 27.2% q/q. The primary does flag the conflict between "slightly below 100%" and the 83% coverage figure, but "check the note" leaves the reader to resolve it.

Something worth adding from the source is the asterisk on the Basel ratios. It says they exclude "the remaining portion related to Bradsaude, which is currently under review by the regulators." The 16.0% total and 12.1% common equity ratios therefore carry a pending regulatory item. Also, the insurance group's net income held at R$2.9 billion partly because its "Others" expense line shrank from R$653 million to R$258 million (my computation: about R$395 million less).

Claude Fable 5.1

The primary is balanced and well sourced. It treats credit costs as the main offset to the headline growth instead of burying them. Its own calculation that market NII supplied about R$202 million of the R$500 million quarterly NII rise is useful context for a 14.6% earnings gain. It also rightly notes that the highlights' "slightly below 100%" does not match the 83% quarterly figure.

Some weaknesses remain. The text says "Stage 3 coverage was 83%", but the source measures "coverage of Stage 3 movements" (provision expense divided by Stage 3 movements before write-offs). That is a flow measure, not coverage of the loan stock. Readers could confuse it with the 168.9% ratio of total provisions to loans more than 90 days overdue. The ROAE paragraph puts the consolidated 16.1%, which excludes the capital increase, next to the insurance group's 22.0%. It never gives the as-reported consolidated figure, so readers may take 16.1% as the headline. The guidance check is selective. It covers fees and insurance but leaves out loan growth of 11.1% y/y against the 8.5% to 10.5% range and nine-month operating expense growth of 3.2% against 6% to 8%. Saying NII net of provisions is "at 67% to 76%" of guidance also gives no sense of direction. By my computation, adding another R$10.73 billion quarter to the R$32.0 billion would give about R$42.7 billion, near the bottom of the range. Finally, "Operating expenses fell 0.7%" hides the mix. Personnel rose 0.9%, and civil, labor and tax contingencies rose 27.2%. The overall fall came from other net operating expenses.

I would add why insurance income fell 8.6% q/q. Financial results dropped 10.4% (R$2,131 million against R$2,379 million) and retained claims rose 3.7%. By line, Health net income fell 8.1% and Capitalization Bonds fell 33.5%. Readers need this to judge whether the "claims ratio under control" description holds.

Claude Sonnet 5

The primary is accurate, and it generally keeps its sourcing honest. It labels its own computations, separates client NII from market NII, and gives the offsetting credit story instead of repeating the headline. Its pairing of the 22.0% insurance ROAE with the capital increase is also fair.

The first weakness is emphasis on the quarter's drivers. It says fees were led by cards and that operating expenses fell 0.7%. Yet the source says business days rose from 61 to 65 q/q. That calendar help is credited to client NII but not to fee income, so the 4.2% fee rise is probably flattered. The expense decline also came mainly from other operating expenses falling 4.3%, which the source links to lower net insurance expenses. Personnel expenses actually rose 0.9%, and contingencies rose 27.2% q/q. "Operating expenses fell" therefore reads cleaner than the detail supports.

Second, the ROAE sentence is ambiguous. The source's 16.1% is footnoted as excluding the capital increase, so the primary does not show the reported ROAE. A reader may take 16.1% as the actual figure. Likewise, "Credit costs were the main offset" is a judgment. The source's own numbers support it, since provisions rose R$657 million against a R$500 million rise in NII (my arithmetic). But it is not stated as such.

Third, the guidance comparison covers three lines (NII net of provisions at 67% to 76% of the range, fee growth, and insurance income growth) but omits loan growth and operating expenses. The source gives loan growth guidance of 8.5% to 10.5%, against 11.1% y/y, though that guidance is an annual range, so comparing it with 11.1% y/y is indicative rather than like for like. It also gives operating expense guidance of 6% to 8%, against 3.2% for nine months.

One thing I would add from the source is the insurance explanation. The insurance financial result fell 10.4% q/q to R$2,131 million, and retained claims rose 3.7% against earned premiums up 0.9%. That explains the 8.6% decline better than saying only that it fell.

Not financial advice — for research and demonstration only.